168 related articles for article (PubMed ID: 32582694)
1. High Cancer Susceptibility Candidate 8 Expression Is Associated With Poor Prognosis of Pancreatic Adenocarcinoma: Validated Analysis Based on Four Cancer Databases.
Wang Y; Yang Y; Wang Y; Li X; Xiao Y; Wang W
Front Cell Dev Biol; 2020; 8():392. PubMed ID: 32582694
[TBL] [Abstract][Full Text] [Related]
2. Identification and Development of Long Non-coding RNA Associated Regulatory Network in Pancreatic Adenocarcinoma.
Zhu W; Gao W; Deng Y; Yu X; Zhu H
Onco Targets Ther; 2020; 13():12083-12096. PubMed ID: 33262608
[TBL] [Abstract][Full Text] [Related]
3. A novel risk score model based on four angiogenesis long non-coding RNAs for prognosis evaluation of pancreatic adenocarcinoma.
Cao G; Chang Y; Yang G; Jiang Y; Han K
Aging (Albany NY); 2022 Nov; 14(22):9090-9102. PubMed ID: 36384673
[TBL] [Abstract][Full Text] [Related]
4. High expression of RNF169 is associated with poor prognosis in pancreatic adenocarcinoma by regulating tumour immune infiltration.
Wang J; Chen H; Deng Q; Chen Y; Wang Z; Yan Z; Wang Y; Tang H; Liang H; Jiang Y
Front Genet; 2022; 13():1022626. PubMed ID: 36685833
[No Abstract] [Full Text] [Related]
5. A Novel miRNA-mRNA Axis Involves in Regulating Transcriptional Disorders in Pancreatic Adenocarcinoma.
Shang X; Shi LE; Taule D; Zhu ZZ
Cancer Manag Res; 2021; 13():5989-6004. PubMed ID: 34377019
[TBL] [Abstract][Full Text] [Related]
6. How hsa-miR-495 performed in the tumorigenesis of pancreatic adenocarcinoma by bioinformatics analysis.
Yang Y; Wang Y; Liu S; Zhao X; Jia R; Xiao Y; Zhang M; Li X; Li J; Wang W
J Cell Biochem; 2019 May; 120(5):7802-7813. PubMed ID: 30485500
[TBL] [Abstract][Full Text] [Related]
7. Screening and validating the core biomarkers in patients with pancreatic ductal adenocarcinoma.
Li Y; Zhu YY; Dai GP; Wu DJ; Gao ZZ; Zhang L; Fan YH
Math Biosci Eng; 2019 Nov; 17(1):910-927. PubMed ID: 31731384
[TBL] [Abstract][Full Text] [Related]
8. SQLE, A Key Enzyme in Cholesterol Metabolism, Correlates With Tumor Immune Infiltration and Immunotherapy Outcome of Pancreatic Adenocarcinoma.
You W; Ke J; Chen Y; Cai Z; Huang ZP; Hu P; Wu X
Front Immunol; 2022; 13():864244. PubMed ID: 35720314
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of CENPL mRNA potentially regulated by miR-340-3p predicts the prognosis of pancreatic cancer patients.
Cui Z; Du L; Wang J; Li Z; Xu J; Ou S; Li D; Li S; Hu H; Chen G; Wu Z
BMC Cancer; 2022 Dec; 22(1):1354. PubMed ID: 36572856
[TBL] [Abstract][Full Text] [Related]
10. Identify potential prognostic indicators and tumor-infiltrating immune cells in pancreatic adenocarcinoma.
Shi T; Gao G
Biosci Rep; 2022 Feb; 42(2):. PubMed ID: 35083488
[TBL] [Abstract][Full Text] [Related]
11. Three-lncRNA signature is a potential prognostic biomarker for pancreatic adenocarcinoma.
Shi X; Zhao Y; He R; Zhou M; Pan S; Yu S; Xie Y; Li X; Wang M; Guo X; Qin R
Oncotarget; 2018 May; 9(36):24248-24259. PubMed ID: 29849937
[TBL] [Abstract][Full Text] [Related]
12. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.
Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y
Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804
[TBL] [Abstract][Full Text] [Related]
13. High Matrix Metalloproteinase 28 Expression is Associated with Poor Prognosis in Pancreatic Adenocarcinoma.
Liu N; Zhong L; Ni G; Lin J; Xie L; Li T; Dan H; Chen Q
Onco Targets Ther; 2021; 14():4391-4406. PubMed ID: 34408436
[TBL] [Abstract][Full Text] [Related]
14. Identification and validation of a novel anoikis-related long non-coding RNA signature for pancreatic adenocarcinoma to predict the prognosis and immune response.
Jiang Y; Ye Y; Huang Y; Wu Y; Wang G; Gui Z; Zhang M; Zhang M
J Cancer Res Clin Oncol; 2023 Nov; 149(16):15069-15083. PubMed ID: 37620430
[TBL] [Abstract][Full Text] [Related]
15. Construction of an RNA-Binding Protein-Related Prognostic Model for Pancreatic Adenocarcinoma Based on TCGA and GTEx Databases.
Wen X; Shao Z; Chen S; Wang W; Wang Y; Jiang J; Ma Q; Zhang L
Front Genet; 2020; 11():610350. PubMed ID: 33584809
[No Abstract] [Full Text] [Related]
16. High expression of syndecan-4 is related to clinicopathological features and poor prognosis of pancreatic adenocarcinoma.
Zhu Y; Zheng D; Lei L; Cai K; Xie H; Zheng J; Yu C
BMC Cancer; 2022 Oct; 22(1):1042. PubMed ID: 36199068
[TBL] [Abstract][Full Text] [Related]
17. Construction of a Competitive Endogenous RNA Network for Pancreatic Adenocarcinoma Based on Weighted Gene Co-expression Network Analysis and a Prognosis Model.
Wang J; Xiang J; Li X
Front Bioeng Biotechnol; 2020; 8():515. PubMed ID: 32548103
[TBL] [Abstract][Full Text] [Related]
18. Identification of a competing endogenous RNA network associated with prognosis of pancreatic adenocarcinoma.
Weng W; Zhang Z; Huang W; Xu X; Wu B; Ye T; Shan Y; Shi K; Lin Z
Cancer Cell Int; 2020; 20():231. PubMed ID: 32536819
[TBL] [Abstract][Full Text] [Related]
19. Competing endogenous RNA (ceRNA) hypothetic model based on comprehensive analysis of long non-coding RNA expression in lung adenocarcinoma.
Wang X; Su R; Guo Q; Liu J; Ruan B; Wang G
PeerJ; 2019; 7():e8024. PubMed ID: 31720124
[TBL] [Abstract][Full Text] [Related]
20. High expression of LAMA3/AC245041.2 gene pair associated with KRAS mutation and poor survival in pancreatic adenocarcinoma: a comprehensive TCGA analysis.
Tian C; Li X; Ge C
Mol Med; 2021 Jun; 27(1):62. PubMed ID: 34134622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]